BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 28985076)

  • 1. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
    Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
    Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
    Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
    Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Three Kinds of Carbohydrate Pharmaceutical Excipients-Fructose, Lactose and Arabic Gum on Intestinal Absorption of Gastrodin through Glucose Transport Pathway in Rats.
    Chen Z; Chen J; Wang L; Wang W; Zheng J; Wu S; Sun Y; Pan Y; Li S; Liu M; Cai Z
    Pharm Res; 2024 Jun; 41(6):1201-1216. PubMed ID: 38834905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.
    Zhang T; Li M; Han X; Nie G; Zheng A
    AAPS PharmSciTech; 2022 May; 23(5):143. PubMed ID: 35578146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of Intranasal Drug Delivery with Intravail
    Rabinowicz AL; Carrazana E; Maggio ET
    Drugs R D; 2021 Dec; 21(4):361-369. PubMed ID: 34435339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.
    Deli MA
    Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
    Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
    Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dodecylmaltoside (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells and rat intestine model.
    Deshmukh DD; Nagilla R; Ravis WR; Betageri GV
    Drug Deliv; 2010 Apr; 17(3):145-51. PubMed ID: 20136582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction with Mixed Micelles in the Intestine Attenuates the Permeation Enhancing Potential of Alkyl-Maltosides.
    Gradauer K; Nishiumi A; Unrinin K; Higashino H; Kataoka M; Pedersen BL; Buckley ST; Yamashita S
    Mol Pharm; 2015 Jul; 12(7):2245-53. PubMed ID: 25874852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
    Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
    Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dodecylmaltoside Modulates Bicellular Tight Junction Contacts To Promote Enhanced Permeability.
    Gradauer K; Iida M; Watari A; Kataoka M; Yamashita S; Kondoh M; Buckley ST
    Mol Pharm; 2017 Dec; 14(12):4734-4740. PubMed ID: 28985076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic analysis for drug permeation through intestinal membrane.
    Hayashi M; Tomita M
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.